Zobrazeno 1 - 10
of 115
pro vyhledávání: '"M V, Ezhov"'
Autor:
M. V. Ezhov, U. V. Chubykina
Publikováno v:
Российский кардиологический журнал, Vol 29, Iss 8 (2024)
Externí odkaz:
https://doaj.org/article/75bad3f41206416899af52bc1500520f
Publikováno v:
Российский кардиологический журнал, Vol 29, Iss 8 (2024)
Despite a variety of lipid-lowering drugs, mostly pelleted, aimed at reducing low-density lipoprotein cholesterol and triglycerides, only a small number of patients achieve their target levels. The reasons are insufficient adherence to treatment, rar
Externí odkaz:
https://doaj.org/article/e21b417a94c64b7eafa7fb8bb1d3ccda
Publikováno v:
Качественная клиническая практика, Vol 0, Iss 4, Pp 108-119 (2024)
The federal program of preferential drug provision in cardiology shows its effectiveness. However, hypercholesterolemia (HCH) remains a significant problem in patients in whom high-dose statin therapy does not provide the target level of low-density
Externí odkaz:
https://doaj.org/article/393eef0942b94c26abf0f4c624ced547
Autor:
I. V. Sergienko, M. V. Ezhov
Publikováno v:
Российский кардиологический журнал, Vol 28, Iss 4S (2023)
The novelty of the 2023 National Guidelines for Lipid Metabolism Disorders is presented regarding the categorization of cardiovascular risk, target and optimal levels of blood lipids, diagnosis and therapeutic approaches to the treatment of dyslipide
Externí odkaz:
https://doaj.org/article/03a7cac463e04ac1a05c1becdea7484c
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 19, Iss 2, Pp 143-150 (2023)
Aim. To study the frequency of prescriptions of various types of lipid-lowering therapy and their effectiveness in outpatient clinical practice based on the results of a questionnaire of primary care physicians.Material and methods. The study was per
Externí odkaz:
https://doaj.org/article/37d179a1ea3a412c8ae7ca9c442b1d30
Autor:
M. V. Ezhov, V. V. Kukharchuk, I. V. Sergienko, A. S. Alieva, M. B. Antsiferov, A. A. Ansheles, G. G. Arabidze, D. M. Aronov, G. P. Arutyunov, N. M. Akhmedzhanov, T. V. Balakhonova, O. L. Barbarash, S. A. Boytsov, M. G. Bubnova, M. I. Voevoda, G. R. Galstyan, A. S. Galyavich, N. B. Gornyakova, V. S. Gurevich, I. I. Dedov, O. M. Drapkina, D. V. Duplyakov, S. Ya. Eregin, A. I. Ershova, O. B. Irtyuga, R. S. Karpov, Yu. A. Karpov, M. A. Kachkovsky, Zh. D. Kobalava, N. A. Koziolova, G. A. Konovalov, V. O. Konstantinov, E. D. Kosmacheva, Yu. V. Kotovskaya, A. I. Martynov, A. N. Meshkov, D. V. Nebieridze, S. V. Nedogoda, A. G. Obrezan, V. E. Oleinikov, S. N. Pokrovsky, Yu. I. Ragino, O. P. Rotar, V. V. Skibitsky, O. G. Smolenskaya, A. A. Sokolov, A. B. Sumarokov, E. Filippov, Yu. Sh. Halimov, I. E. Chazova, I. I. Shaposhnik, M. V. Shestakova, S. S. Yakushin, E. V. Shlyakhto
Publikováno v:
Российский кардиологический журнал, Vol 28, Iss 5 (2023)
The Russian Society of Cardiology (RKO)With the participation of: The National Society for the Study of Atherosclerosis (NOA), the Russian Association of Endocrinologists (RAE), the Russian Society of Cardiosomatic Rehabilitation and Secondary Preven
Externí odkaz:
https://doaj.org/article/74d801ab1b2e4d4c855890c00ec1b9f6
Autor:
M. M. Tanashyan, N. A. Shamalov, I. A. Voznyuk, S. N. Yanishevsky, O. I. Vinogradov, D. R. Khasanova, O. V. Tikhomirova, V. A. Parfenov, E. V. Oshchepkova, M. V. Ezhov, V. S. Gurevich, V. V. Arkhipov
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 14, Iss 4, Pp 108-113 (2022)
On July 6, 2022, an interdisciplinary meeting of the Expert Council was held on the topic "Control of dyslipidemia in the prevention of acute and recurrent ischemic cerebrovascular accidents". The conclusion of the Expert Council was that after verif
Externí odkaz:
https://doaj.org/article/5131cf7e37dc4328a08303b97dcf28e3
Publikováno v:
Медицинский совет, Vol 0, Iss 4, Pp 82-88 (2022)
The COVID-19 (COronaVIrus Disease 2019) pandemic caused by SARS-CoV-2 (Severe Acute Respiratory Syndrome CoronaVirus 2) continues to be a global threat to people and health systems. As of March 21, 2022, there are more than 460 million cases and more
Externí odkaz:
https://doaj.org/article/d1af5912d1b04d1cb0857549547062ef
Autor:
S. A. Boytsov, M. A. Piradov, M. M. Tanashyan, I. A. Voznjouk, M. V. Ezhov, E. V. Oschepkova, I. V. Sergienko, N. A. Shamalov, S. N. Yanishevskiy
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 17, Iss 6, Pp 927-930 (2022)
The existing system of medical care for patients with acute cerebrovascular accident of atherothrombotic genesis, namely lipid metabolism disorders, the modern evidence base for lipid-lowering therapy in this category of patients and the feasibility
Externí odkaz:
https://doaj.org/article/9c5d9fbb44e74ac68f38b0f9f98d48c9
Publikováno v:
Атеротромбоз, Vol 11, Iss 2, Pp 56-75 (2022)
According to the latest international and Russian guidelines for the treatment of dyslipidemias, statins are defined as the main group of drugs that significantly reduce the level of low-density lipoprotein cholesterol (LDL-C) effectively prevent ath
Externí odkaz:
https://doaj.org/article/6aa0e9275c88428d841ee99af5366869